Kanzonol M



Compound IDCDAMM02488
Common nameKanzonol M
IUPAC name7-hydroxy-3-[2-hydroxy-4-methoxy-3-(3-methylbut-2-enyl)phenyl]-5-methoxy-3,4-dihydro-2H-chromene-8-carbaldehyde
Molecular formulaC23H26O6

Experimental data

Retention time4.5
Adduct[M+Na]+
Actual mz421.163
Theoretical mz421.162
Error1.62
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.3218

Identifiers and class information

Inchi keyKZQAGRHRFKIERV-UHFFFAOYNA-N
SmilesO=CC1=C(O)C=C(OC)C2=C1OCC(C3=CC=C(OC)C(=C3O)CC=C(C)C)C2
SuperclassPhenylpropanoids and polyketides
ClassIsoflavonoids

Pharmacokinetic properties

Number of descriptor values(#stars)1
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)7
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)398.455
Computed dipole moment(dipole)7.063
Total solvent accessible surface area (SASA)715.086
Hydrophobic component of SASA (FOSA)449.847
Hydrophilic component of SASA (FISA)147.379
Pie component of the SASA (PISA)117.861
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1283.37
Number of hydrogen bond donors (donorHB)1
Number of hydrogen bond acceptors (accptHB)4.75
Free energy of solvation of dipole (dip^2/V)0.0388741
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0066426
Globularity descriptor (glob)0.798684
Predicted polarizability in cubic angstroms (QPpolrz)41.837
Predicted hexadecane/gas partition coefficient (QPlogPC16)12.284
Predicted octanol/gas partition coefficient (QPlogPoct)18.095
Predicted water/gas partition coefficient (QPlogPw)7.843
Predicted octanol/water partition coefficient (QPlogPo/w)4.467
Predicted aqueous solubility (QPlogS)-6.404
Conformation-independent predicted aqueous solubility (CIQPlogS)-6.183
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-5.352
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)396.56
Predicted brain/blood partition coefficient (QPlogBB)-1.399
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)182.041
Predicted skin permeability, log Kp (QPlogKp)-3.148
PM3 calculated ionization potential (IP(ev))8.929
PM3 calculated electron affinity (EA(eV))0.174
Number of likely metabolic reactions (#metab)9
Prediction of binding to human serum albumin (QPlogKhsa)0.879
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)100
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)94.43
Number of nitrogen and oxygen atoms (#NandO)6
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P19838NFKB1Nuclear factor NF-kappa-B p105 subunitT83145SEA
P11926ODC1Ornithine decarboxylaseT60366SEA
P18031PTPN1Protein-tyrosine phosphatase 1BT16347SwissTargetPrediction and SEA
P20839IMPDH1Inosine-5'-monophosphate dehydrogenase 1T40111SEA
P12268IMPDH2Inosine-5'-monophosphate dehydrogenase 2T89360SEA
O14980XPO1Exportin-1T51407SEA
P14679TYRTyrosinaseT97035SwissTargetPrediction and SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T83145DI0218Irritable bowel syndrome[ICD-11: DD91]P19838NFKB1
T83145DI0366Rheumatoid arthritis[ICD-11: FA20]P19838NFKB1
T60366DI0020African trypanosomiasis[ICD-11: 1F51]P11926ODC1
T16347DI0009Acute diabete complication[ICD-11: 5A2Y]P18031PTPN1
T16347DI0062Breast cancer[ICD-11: 2C60-2C6Y]P18031PTPN1
T16347DI0308Obesity[ICD-11: 5B80-5B81]P18031PTPN1
T16347DI0417Type 2 diabetes mellitus[ICD-11: 5A11]P18031PTPN1
T40111DI0062Breast cancer[ICD-11: 2C60-2C6Y]P20839IMPDH1
T40111DI0179Hepatitis virus infection[ICD-11: 1E50-1E51]P20839IMPDH1
T40111DI0250Mature B-cell lymphoma[ICD-11: 2A85]P20839IMPDH1
T40111DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P20839IMPDH1
T40111DI0413Transplant rejection[ICD-11: NE84]P20839IMPDH1
T89360DI0413Transplant rejection[ICD-11: NE84]P12268IMPDH2
T51407DI0234Liposarcoma[ICD-11: 2B59]O14980XPO1
T51407DI0274Multiple myeloma[ICD-11: 2A83]O14980XPO1
T51407DI0395Stomach cancer[ICD-11: 2B72]O14980XPO1
T97035DI0007Acquired hypermelanosis[ICD-11: ED60]P14679TYR
T97035DI0008Acquired hypomelanotic disorder[ICD-11: ED63]P14679TYR

Copyright © 2025